Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (1.415)

1

Pharmacokinetics/pharmacodynamics of ivosidenib in advanced IDH1-mutant cholangiocarcinoma : findings from the phase III ClarIDHy study

enthalten in: Cancer chemotherapy and pharmacology | 2024

von Fan, B. | Abou-Alfa, G. | Zhu, A. | +7

2

Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer

enthalten in: The New England journal of medicine | 2024

von Wu, Y. | Dziadziuszko, R. | Ahn, J. | +120

3

Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia : a randomized phase 3 trial with 5-year outcomes

enthalten in: Journal of cancer research and clinical oncology | 2024

von Tian, J. | Song, Y. | Zhang, G. | +24

4

The Impact of Immunogenicity on the Pharmacokinetics, Efficacy, and Safety of Sotatercept in a Phase III Study of Pulmonary Arterial Hypertension

enthalten in: Clinical pharmacology and therapeutics | 2024

von Liao, K. | Mackenzie, H. | Ait-Oudhia, S. | +5

5

CALGB 80802 (Alliance) : Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma

enthalten in: Cancer research communications | 2024

von Abou-Alfa, G. | Geyer, S. | Nixon, A. | +18

6

Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer

enthalten in: The New England journal of medicine | 2024

von Powles, T. | Valderrama, B. | Gupta, S. | +122

7

Long-Term Follow-Up of the RESORT Study (E4402) : A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular Lymphoma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Kahl, B. | Jegede, O. | Peterson, C. | +7

8

Dexamethasone-sparing on days 2-4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin : a randomized phase III trial (SPARED Trial)

enthalten in: British journal of cancer | 2024

von Minatogawa, H. | Izawa, N. | Shimomura, K. | +27

9

Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours : a single-centre, open-label, non-inferiority, randomised, controlled, phase 3 trial

enthalten in: The Lancet. Oncology | 2024

von Bajpai, J. | Kapu, V. | Rath, S. | +16

10

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer : The Phase III DUO-E Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Westin, S. | Moore, K. | Chon, H. | +128

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[142]